Your browser is no longer supported. Please, upgrade your browser.
DVAX Dynavax Technologies Corporation monthly Stock Chart
DVAX [NASD]
Dynavax Technologies Corporation
Index- P/E- EPS (ttm)-2.87 Insider Own0.36% Shs Outstand39.76M Perf Week-1.06%
Market Cap184.88M Forward P/E- EPS next Y-2.35 Insider Trans1.02% Shs Float38.43M Perf Month-59.03%
Income-117.60M PEG- EPS next Q-0.85 Inst Own83.50% Short Float27.63% Perf Quarter-61.85%
Sales4.40M P/S42.02 EPS this Y5.90% Inst Trans-2.12% Short Ratio5.20 Perf Half Y-68.09%
Book/sh2.81 P/B1.65 EPS next Y26.80% ROA-65.90% Target Price22.00 Perf Year-81.96%
Cash/sh2.75 P/C1.69 EPS next 5Y- ROE-78.60% 52W Range3.20 - 29.86 Perf YTD-80.75%
Dividend- P/FCF- EPS past 5Y14.10% ROI-57.10% 52W High-84.43% Beta1.99
Dividend %- Quick Ratio3.90 Sales past 5Y-29.90% Gross Margin- 52W Low45.31% ATR0.72
Employees234 Current Ratio3.90 Sales Q/Q-83.30% Oper. Margin- RSI (14)34.96 Volatility9.15% 10.94%
OptionableYes Debt/Eq0.00 EPS Q/Q-9.20% Profit Margin- Rel Volume0.94 Prev Close4.80
ShortableYes LT Debt/Eq0.00 EarningsNov 07 BMO Payout- Avg Volume2.04M Price4.65
Recom2.30 SMA20-14.05% SMA50-44.61% SMA200-67.13% Volume1,920,300 Change-3.13%
Apr-28-16Downgrade RBC Capital Mkts Outperform → Sector Perform $48 → $17
Apr-27-16Downgrade JP Morgan Overweight → Neutral
Nov-30-15Initiated RBC Capital Mkts Outperform $48
Nov-25-13Upgrade MLV & Co Hold → Buy $1.50 → $5
Feb-25-13Downgrade MLV & Co Buy → Hold
Nov-16-12Reiterated MLV & Co Buy $10 → $7.50
Jan-04-12Initiated MLV & Co Buy $8
Nov-09-10Reiterated Wedbush Outperform $6 → $8
Nov-08-10Initiated Jefferies Buy $4
May-13-10Upgrade Wedbush Neutral → Outperform $2.60 → $6
Mar-20-09Initiated Wedbush Morgan Buy $1.20
Oct-22-08Downgrade Oppenheimer Outperform → Perform
May-19-08Reiterated Susquehanna Financial Positive $7 → $5
May-19-08Downgrade Bear Stearns Outperform → Peer Perform
Mar-18-08Downgrade Merriman Curhan Ford Buy → Neutral
Feb-22-08Upgrade Oppenheimer Perform → Outperform $8.50
Oct-03-07Initiated Credit Suisse Outperform $8
Jun-06-07Initiated Susquehanna Financial Positive
Feb-26-07Downgrade JMP Securities Mkt Outperform → Mkt Perform
Dec-10-16 07:32PM  Is Celldex Therapeutics, Inc. (CLDX) a Good Stock To Buy? at Insider Monkey
Dec-09-16 10:11PM  INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Dynavax Technologies Corporation and Encourages Investors with Losses to Contact the Firm Accesswire
08:12PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Dynavax Technologies Corporation of Class Action Lawsuit and Upcoming Deadline - DVAX Accesswire
Dec-07-16 03:18PM  SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Dynavax Technologies Corporation and Encourages Investors with Losses to Contact the Firm Accesswire
01:51PM  Glancy Prongay & Murray LLP Announces the Filing of a Securities Class Action on Behalf of Dynavax Technologies Corporation Investors and Encourages Investors to Contact the Firm Business Wire
11:48AM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Dynavax Technologies Corporation of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 17, 2017 - DVAX Accesswire
Dec-06-16 06:26PM  Is Dynavax Technologies Corporation (DVAX) A Good Stock To Buy? at Insider Monkey
05:21PM  SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Dynavax Technologies Corporation and Encourages Investors with Losses to Contact the Firm Accesswire
03:00PM  Robbins Arroyo LLP: Dynavax Technologies Corporation (DVAX) Misled Shareholders According to a Recently Filed Class Action Business Wire
11:40AM  INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Dynavax Technologies Corporation and Encourages Investors with Losses to Contact the Firm Accesswire
10:16AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Dynavax Technologies Corporation (DVAX) & Lead Plaintiff Deadline: January 17, 2017 Accesswire
08:33AM  3 Beaten-Up Healthcare Stocks: Are They Bargains? at Motley Fool
Dec-05-16 04:36PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits +9.57%
01:05PM  10 Major Pharma and FDA Catalysts Coming in December at 24/7 Wall St.
07:00AM  Dynavax Presents Clinical Data from Lead Cancer Immunotherapy Candidate, SD-101, in Combination with Targeted Low-Dose Radiation, at ASH Annual Meeting Marketwired
Dec-04-16 04:40PM  5 Stocks Poised for Major Breakouts--Gold, Pharma and Tech
Dec-02-16 10:37PM  INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Dynavax Technologies Corporation and Encourages Investors with Losses to Contact the Firm Accesswire +8.05%
08:00PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Dynavax Technologies Corporation of Class Action Lawsuit and Upcoming Deadline DVAX GlobeNewswire
Dec-01-16 04:28PM  Why These 3 Healthcare Stocks Lost Half Their Value in November
02:30PM  SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Dynavax Technologies Corporation and Encourages Investors with Losses to Contact the Firm Accesswire
11:44AM  Lifshitz & Miller Law Firm Announces Investigation of Cempra, Inc., Commvault Systems, Inc., Dakota Plains Holdings, Inc., Diplomat Pharmacy, Inc., Dynavax Technologies Corporation, Endologix, Inc., OneMain Holdings, Inc. and StoneMor Partn PR Newswire
07:00AM  Dynavax to Webcast Cancer R&D Day on December 9, 2016 Marketwired
Nov-30-16 07:00AM  Dynavax to Present Clinical Data from Immuno-oncology Product Candidate, SD-101 Marketwired -9.47%
Nov-29-16 07:21PM  IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Dynavax Technologies Corporation and Encourages Investors with Losses to Contact the Firm Accesswire
03:10PM  ETFs with exposure to Dynavax Technologies Corp. : November 29, 2016
10:14AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Dynavax Technologies Corporation (DVAX) & Lead Plaintiff Deadline: January 17, 2017 Accesswire
Nov-28-16 12:50PM  IMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Dynavax Technologies Corporation and Encourages Investors with Losses to Contact the Firm Accesswire -8.00%
10:41AM  INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Dynavax Technologies Corporation of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 17, 2017 - DVAX Marketwired
09:47AM  Dynavax Technologies Corp. :DVAX-US: Earnings Analysis: Q3, 2016 By the Numbers : November 28, 2016
Nov-27-16 06:00AM  SHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Dynavax Technologies Corporation To Contact Brower Piven Before The Lead Plaintiff Dead GlobeNewswire
Nov-25-16 08:00PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Dynavax Technologies Corporation of Class Action Lawsuit and Upcoming Deadline - DVAX PR Newswire
Nov-23-16 11:49AM  SHAREHOLDER ALERT: Goldberg Law PC Announces a Securities Class Action Lawsuit against Dynavax Technologies Corporation and Encourages Investors with Losses to Contact the Firm Business Wire -6.73%
10:10AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Dynavax Technologies Corporation (DVAX) & Lead Plaintiff Deadline: January 17, 2017 GlobeNewswire
Nov-22-16 12:14PM  IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Dynavax Technologies Corporation and Encourages Investors with Losses to Contact the Firm Business Wire +9.47%
10:30AM  DVAX SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of a Class Action Involving Dynavax Technologies Corporation and a Lead Plaintiff Deadline of January 17, 2017 GlobeNewswire
Nov-21-16 07:39PM  SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Dynavax Technologies Corporation and Encourages Investors with Losses to Contact the Firm Business Wire
07:00PM  Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Dynavax Technologies Corporation (DVAX) GlobeNewswire
03:15PM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Dynavax Technologies Corporation (DVAX) & Lead Plaintiff Deadline: January 17, 2017 PR Newswire
Nov-19-16 10:15AM  4 Companies That Destroyed Shareholders Last Week at 24/7 Wall St.
Nov-18-16 09:01PM  INVESTOR ALERT: Goldberg Law PC Announces the Filing of a Securities Class Action Lawsuit against Dynavax Technologies Corporation and Encourages Investors with Losses to Contact the Firm Business Wire
06:56PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Dynavax Technologies Corporation of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 17, 2017 DVAX GlobeNewswire
06:10PM  EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Dynavax Technologies Corporation Business Wire
04:56PM  Pomerantz Law Firm Announces the Filing of a Class Action against Dynavax Technologies Corporation and Certain Officers DVAX GlobeNewswire
01:16PM  SHAREHOLDER ALERT: Goldberg Law PC Announces an Investigation of Dynavax Technologies Corporation and Advises Investors to Contact the Firm Business Wire
Nov-16-16 02:30PM  FDA Rejects Dynavax's Hep B Vaccine Again (DVAX) at Investopedia
01:04PM  DYNAVAX TECHNOLOGIES CORP Financials
Nov-15-16 08:11AM  Dynavax Technologies Shares Decimated -- Is There Any Hope for Heplisav? at Motley Fool +15.85%
06:25AM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits
Nov-14-16 06:02PM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Dynavax Technologies Corporation (DVAX) PR Newswire -64.66%
05:12PM  Why Anheuser-Busch InBev, TransDigm Group, and Dynavax Technologies Slumped Today at Motley Fool
04:08PM  Why Dynavax Technologies Shares Are Crashing 63% Today at Motley Fool
04:04PM  Dynavax, Nokia Tumble into Mondays 52-Week Low Club at 24/7 Wall St.
04:02PM  Supernus, Puma Among 5 Biotech Stock Winners, Losers Monday
03:06PM  Why did the stock of this East Bay drugmaker plummet? at bizjournals.com
02:45PM  Stocks Waver as Wall Street's Trump Rally Fades
12:48PM  How to Trade Monday's Most Active Stocks - Facebook, Dynavax, Barrick Gold, More
11:37AM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces the Commencement of an Investigation Involving Possible Securities Fraud Violations by Certain Officers and Directors of Dynavax Technologies Corporation Business Wire
11:02AM  New Phase IV Data On VBI Vaccines, Inc. (VBIV) HBV Vaccine Show It Can Carve Out A Market From GlaxoSmithKline PLC (ADR) (GSK) at Insider Monkey
10:50AM  Why Dynavax Shares Are in Freefall at 24/7 Wall St.
08:15AM  Dynavax's stock plunges after disappointing FDA response to Hep-B treatment at MarketWatch
07:34AM  Dynavax Shares Fall on FDA Rejection of Hepatitis B Vaccine
06:30AM  Dynavax Receives Complete Response Letter from U.S. Food and Drug Administration for Biologics License Application for HEPLISAV-B Marketwired
Nov-11-16 05:00PM  Trump Victory Gives Life to Pharma,Biotech - Take a Look at VBI Vaccines
12:48PM  ETFs with exposure to Dynavax Technologies Corp. : November 11, 2016
Nov-10-16 10:40AM  3 Attractive Biotech Stocks With Upcoming Catalysts (VCEL, DVAX) at Investopedia
08:26AM  Dynavax Technologies Corp. breached its 50 day moving average in a Bullish Manner : DVAX-US : November 10, 2016
Nov-09-16 04:33PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits +9.13%
11:00AM  Dynavax Presents Early Clinical Data from Lead Cancer Immunotherapy Candidate, SD-101, at Society for Melanoma Research Marketwired
Nov-07-16 05:31PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and
04:45PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 10-Q, Quarterly Report
06:10AM  Dynavax Technologies reports 3Q loss
06:00AM  Dynavax Reports Third Quarter 2016 Financial Results and Company Update Marketwired
Oct-27-16 08:15AM  Blog Coverage Dynavax Releases New Data Showing That its Vaccine HEPLISAV-B Offers Higher Seroprotection Against Hepatitis B Accesswire
08:02AM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Sta
07:00AM  Dynavax Secures Committed Financing From Deerfield for $100 Million of Senior Secured Notes Marketwired
Oct-26-16 09:00AM  Dynavax Presents Data Showing That HEPLISAV-B Provides Significantly Higher Seroprotection Rates Against Hepatitis B Infection in Populations Known to Have a Reduced Immune Response to Currently Licensed Vaccines Marketwired
Oct-18-16 09:23AM  Biotech Review DVAX Vaccine Faces Crucial PDUFA Date, CLDX Seeks Fast-Track Orphan Drug Status CNW Group
Oct-16-16 11:45AM  What Will Dynavax Do if Heplisav-B Is Rejected? at Motley Fool
Oct-11-16 06:31AM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits
Oct-09-16 07:00AM  Dynavax Presents Early Clinical Data From Lead Cancer Immunotherapy Candidate, SD-101, at ESMO Annual Congress Marketwired
Oct-07-16 02:51PM  Steven Cohen Increases Position in Dynavax
Oct-04-16 05:38PM  Why Dynavax Technologies Fell 13% Today at Motley Fool -12.90%
10:49AM  FDA Precedent Suggests Dynavax Hep B Vaccine Faces High Rejection Risk
Oct-03-16 06:41PM  Why Winnebago Industries, Janus Capital Group, and Dynavax Technologies Jumped Today at Motley Fool +18.97%
11:33AM  Why Allergan, eBay, Dynavax, KBR, and More Are Trending at Insider Monkey
06:32AM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Other Events
Sep-30-16 07:00AM  Biotech Stock Mailbag: Dynavax, Puma, Ariad
Sep-20-16 09:10AM  Dynavax Technologies Corp (DVAX): Glenhill Advisors Adds to Its Position at Insider Monkey
Sep-16-16 10:05AM  5 Stocks to Trade for Big Breakout Gains
Sep-14-16 10:02AM  How one investor is playing Dynavax
Sep-09-16 10:24AM  4 Biotechs Set to Provide a Shot in the Arm
Sep-07-16 10:56AM  Dynavax Rebounds on Same PDUFA Date for Heplisav BLA -8.14%
Sep-06-16 03:11PM  Why Dynavax Technologies Is Gaining Back 27% Today at Motley Fool +28.32%
12:29PM  Dynavax stock drops then gains 30% after canceled FDA drug review confounds investors at MarketWatch
12:17PM  Tuesdays Movers and Shakers: Cummins, Dynavax & More at Insider Monkey
10:34AM  Here's a Reason Why Dynavax Technologies (DVAX) Stock Is Soaring Today
10:25AM  ETFs with exposure to Dynavax Technologies Corp. : September 6, 2016
10:15AM  Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Dynavax Technologies Corporation (DVAX) PR Newswire
06:16AM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits
04:02AM  Biotech Movers and Shakers: Threshold Pharmaceuticals, Inc. (THLD) and Dynavax Technologies Corporation (DVAX) at Insider Monkey
Dynavax Technologies Corporation, a clinical-stage biopharmaceutical company, discovers and develops novel vaccines and therapeutics in the United States. Its development programs focuses on vaccine adjuvants, cancer immunotherapy, and autoimmune and inflammatory diseases. The company's lead products include HEPLISAV-B, an investigational adult hepatitis B vaccine, which is in Phase III clinical trials; and SD-101, a C Class CpG TLR9 agonist for the treatment of cancer, which is in Phase I/II multicenter clinical trial. Its product portfolio also comprises AZD1419 for the treatment of asthma, which is in Phase II clinical trial; DV1179, a TLR7/9 inhibitor that is in Phase Ib/IIa for the treatment of autoimmune and inflammatory conditions; and DV281 and CpG-Nanoparticles, which are in preclinical studies for cancer immunotherapy. It has a research collaboration and license agreement with AstraZeneca AB to conduct a Phase IIa safety and efficacy trial of AZD1419 for the treatment of asthma; and strategic alliance with GlaxoSmithKline to discover, develop, and commercialize TLR inhibitors. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. Dynavax Technologies Corporation was founded in 1996 and is headquartered in Berkeley, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Janssen RobertVice PresidentJun 28Buy13.681,45219,8636,048Jun 30 06:51 AM
Gray EddieCEO and DirectorMay 20Buy15.572,75042,8205,250May 23 09:10 AM
Janssen RobertVice PresidentMay 12Buy15.121,00015,1201,000May 13 09:30 AM